|
Volumn 39, Issue SUPPL. 2, 2001, Pages 209-211
|
Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells
|
Author keywords
Breast cancer cells; Collagen; Pro drug; Prolidase; Proline analogue of melphalan
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHEMICAL COMPOUND;
COLLAGEN;
MELPHALAN;
MELPHALAN PLUS PROLINE;
PRODRUG;
PROLINE DERIVATIVE;
PROLINE DIPEPTIDASE;
UNCLASSIFIED DRUG;
BREAST CANCER;
CELL STRAIN MCF 7;
CHEMICAL BOND;
COLLAGEN METABOLISM;
COMPARATIVE STUDY;
CONCENTRATION (PARAMETERS);
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOSOL;
CYTOSOLIC FRACTION;
DOSE RESPONSE;
DRUG CONJUGATION;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG PENETRATION;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME SUBSTRATE COMPLEX;
HUMAN;
HUMAN CELL;
MOLECULAR DYNAMICS;
MOLECULAR WEIGHT;
MINK CELL FOCUS-FORMING VIRUS;
|
EID: 0035682742
PISSN: 02398508
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (10)
|